Yield10 Competitors

YTEN Stock  USD 0.01  0.00  0.00%   
Yield10 Bioscience competes with KS AG, Intrepid Potash, Bioceres Crop, Itafos, and Verde Agritech; as well as few others. The company conducts business under Biotechnology sector and is part of Health Care industry. Analyzing Yield10 Bioscience competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Yield10 Bioscience to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Yield10 Bioscience Correlation with its peers.
To learn how to invest in Yield10 Stock, please use our How to Invest in Yield10 Bioscience guide.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Yield10 Bioscience competition on your existing holdings.
  
At this time, Yield10 Bioscience's Return On Capital Employed is very stable compared to the past year. As of the 1st of March 2025, Return On Equity is likely to grow to 5.50, though Return On Tangible Assets are likely to grow to (4.04). At this time, Yield10 Bioscience's Non Current Assets Total are very stable compared to the past year. As of the 1st of March 2025, Non Currrent Assets Other is likely to grow to about 388.3 K, while Total Assets are likely to drop about 3.3 M.
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Yield10 Bioscience's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.0250.77
Details
Intrinsic
Valuation
LowRealHigh
0.000.150.85
Details
Naive
Forecast
LowNextHigh
0.00050.0290.94
Details
1 Analysts
Consensus
LowTargetHigh
2.582.833.14
Details

Yield10 Bioscience Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Yield10 Bioscience and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Yield10 and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Yield10 Bioscience does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
YARIYIPI
MBCFKPLUY
AVDIPI
AVDYARIY
YARIYKPLUY
BHILBIOX
  
High negative correlations   
BHILMBCF
MBCFBIOX
LVROVNPKF
BIOXKPLUY
BHILKPLUY
LVROIPI

Risk-Adjusted Indicators

There is a big difference between Yield10 Stock performing well and Yield10 Bioscience Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Yield10 Bioscience's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
KPLUY  1.80  0.27  0.12  0.45  1.86 
 6.97 
 13.69 
IPI  2.03  0.01  0.00 (0.01) 0.00 
 3.73 
 16.60 
CGA  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
BIOX  2.94 (0.63) 0.00  5.71  0.00 
 6.53 
 26.87 
MBCF  1.14  0.26  0.12 (0.41) 1.09 
 4.17 
 11.54 
VNPKF  5.69  0.74  0.08  0.51  6.13 
 13.73 
 52.39 
YARIY  1.33  0.02  0.01  0.00  1.93 
 2.70 
 10.57 
BHIL  8.03 (1.28) 0.00 (0.49) 0.00 
 12.55 
 153.37 
AVD  2.39 (0.20) 0.00 (0.17) 0.00 
 4.83 
 15.45 
LVRO  3.77  0.20  0.04  0.24  4.81 
 8.65 
 26.24 

Cross Equities Net Income Analysis

Compare Yield10 Bioscience and related stocks such as KS AG DRC, Intrepid Potash, and CGA Old Net Income Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity
2010201120122013201420152016201720182019202020212022202320242025
IPI36 M109.4 M87.4 M22.3 M9.8 M(524.8 M)(66.6 M)(22.9 M)11.8 M13.6 M(27.2 M)249.8 M72.2 M(35.7 M)(32.1 M)(30.5 M)
BIOX(5.9 M)(5.9 M)(5.9 M)(5.9 M)(5.9 M)(1.2 M)(11.8 M)(11 M)(18.4 M)3.4 M(6.9 M)(7.2 M)18.8 M3.2 M(1.2 M)(1.3 M)
BHIL(43.9 M)(43.9 M)(43.9 M)(43.9 M)(43.9 M)(43.9 M)(43.9 M)(43.9 M)(43.9 M)(43.9 M)(64.5 M)(126.2 M)(127.9 M)(115.3 M)(103.8 M)(109 M)
AVD1000 K22.1 M36.9 M34.4 M4.8 M6.6 M12.8 M20.3 M24.2 M13.6 M15.2 M18.6 M27.4 M7.5 M8.6 M11.2 M
LVRO(108.7 M)(108.7 M)(108.7 M)(108.7 M)(108.7 M)(108.7 M)(108.7 M)(108.7 M)(108.7 M)(108.7 M)38.4 M78.2 M(260.7 M)(762.5 M)(686.2 M)(651.9 M)
ICL(42.4 M)1.5 B1.3 B818.6 M463.6 M509 M(122 M)364 M1.2 B475 M24 M783 M2.2 B647 M744 M751.3 M
FMC152.5 M365.9 M416.2 M293.9 M307.5 M489 M209.1 M535.8 M502.1 M477.4 M552.4 M739.6 M736.5 M1.3 B1.5 B1.6 B
CF(74.2 M)1.5 B1.8 B1.5 B1.4 B699.9 M(277 M)358 M290 M493 M432 M1.3 B3.3 B1.5 B1.2 B793 M
MOS111.7 M2.5 B1.9 B1.9 BBB297.8 M(107.2 M)470 M(1 B)666.1 M1.6 B3.6 B1.2 B174.9 M166.2 M
NTR88.9 M3.1 B2.1 B1.8 B1.5 B1.3 B336 M327 M3.6 B992 M459 M3.2 B7.7 B1.3 B674 M1.1 B
SMG(6.9 M)106.5 M161.1 M166.5 M159.8 M320.3 M218.3 M63.7 M460.7 M387.4 M512.5 M(437.5 M)(380.1 M)(34.9 M)(40.1 M)(38.1 M)
CTVA503 M503 M503 M503 M503 M503 M503 M2.5 B(5 B)(270 M)681 M1.8 B1.1 B735 M907 M952.4 M

Yield10 Bioscience and related stocks such as KS AG DRC, Intrepid Potash, and CGA Old Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Yield10 Bioscience financial statement analysis. It represents the amount of money remaining after all of Yield10 Bioscience operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Yield10 Bioscience Competitive Analysis

The better you understand Yield10 Bioscience competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Yield10 Bioscience's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Yield10 Bioscience's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
YTEN KPLUY IPI BIOX MBCF VNPKF YARIY BHIL AVD LVRO
 0.00 
 0.01 
Yield10
 4.14 
 6.95 
KPLUY
 0.08 
 26.09 
Intrepid
 4.51 
 4.02 
Bioceres
 3.25 
 1.49 
Itafos
 30.61 
 0.64 
Verde
 2.62 
 14.14 
Yara
 8.70 
 0.84 
Benson
 1.15 
 5.14 
American
 1.00 
 4.94 
Lavoro
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
Profit Margin
EBITDA
Operating Margin
Current Valuation
Price To Book
Retained Earnings
Current Asset
Five Year Return
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Annual Yield
Total Debt
Return On Equity
Z Score
Return On Asset
Number Of Shares Shorted
Book Value Per Share
Current Liabilities
Total Asset
Debt To Equity
Short Ratio
Target Price
Last Dividend Paid
Shares Owned By Institutions
Market Capitalization
Price To Earning
Price To Earnings To Growth
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Cash And Equivalents
Cash Per Share
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Yield10 Bioscience Competition Performance Charts

Five steps to successful analysis of Yield10 Bioscience Competition

Yield10 Bioscience's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Yield10 Bioscience in relation to its competition. Yield10 Bioscience's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Yield10 Bioscience in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Yield10 Bioscience's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Yield10 Bioscience, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Yield10 Bioscience position

In addition to having Yield10 Bioscience in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Large Value Funds Thematic Idea Now

Large Value Funds
Large Value Funds Theme
Funds or Etfs that invest in the undervalued stocks of large-sized companies. The Large Value Funds theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Large Value Funds Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Yield10 Bioscience offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Yield10 Bioscience's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Yield10 Bioscience Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Yield10 Bioscience Stock:
Check out Yield10 Bioscience Correlation with its peers.
To learn how to invest in Yield10 Stock, please use our How to Invest in Yield10 Bioscience guide.
You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Yield10 Bioscience. If investors know Yield10 will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Yield10 Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(20.14)
Revenue Per Share
1.472
Quarterly Revenue Growth
4
Return On Assets
(1.78)
Return On Equity
(15.08)
The market value of Yield10 Bioscience is measured differently than its book value, which is the value of Yield10 that is recorded on the company's balance sheet. Investors also form their own opinion of Yield10 Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Yield10 Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Yield10 Bioscience's market value can be influenced by many factors that don't directly affect Yield10 Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Yield10 Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Yield10 Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Yield10 Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.